890 related articles for article (PubMed ID: 29359192)
1. Targeted Phenotypic Screening in
Subramanian G; Belekar MA; Shukla A; Tong JX; Sinha A; Chu TTT; Kulkarni AS; Preiser PR; Reddy DS; Tan KSW; Shanmugam D; Chandramohanadas R
mSphere; 2018; 3(1):. PubMed ID: 29359192
[TBL] [Abstract][Full Text] [Related]
2. Whole-Cell Phenotypic Screening of Medicines for Malaria Venture Pathogen Box Identifies Specific Inhibitors of
Patra AT; Hingamire T; Belekar MA; Xiong A; Subramanian G; Bozdech Z; Preiser P; Shanmugam D; Chandramohanadas R
Antimicrob Agents Chemother; 2020 Apr; 64(5):. PubMed ID: 32071059
[TBL] [Abstract][Full Text] [Related]
3. Screening the Medicines for Malaria Venture Pathogen Box for invasion and egress inhibitors of the blood stage of Plasmodium falciparum reveals several inhibitory compounds.
Dans MG; Weiss GE; Wilson DW; Sleebs BE; Crabb BS; de Koning-Ward TF; Gilson PR
Int J Parasitol; 2020 Mar; 50(3):235-252. PubMed ID: 32135179
[TBL] [Abstract][Full Text] [Related]
4. Characterization of Plasmodium Atg3-Atg8 Interaction Inhibitors Identifies Novel Alternative Mechanisms of Action in Toxoplasma gondii.
Varberg JM; LaFavers KA; Arrizabalaga G; Sullivan WJ
Antimicrob Agents Chemother; 2018 Feb; 62(2):. PubMed ID: 29158278
[TBL] [Abstract][Full Text] [Related]
5. Targeted Structure-Activity Analysis of Endochin-like Quinolones Reveals Potent Qi and Qo Site Inhibitors of Toxoplasma gondii and Plasmodium falciparum Cytochrome bc
McConnell EV; Bruzual I; Pou S; Winter R; Dodean RA; Smilkstein MJ; Krollenbrock A; Nilsen A; Zakharov LN; Riscoe MK; Doggett JS
ACS Infect Dis; 2018 Nov; 4(11):1574-1584. PubMed ID: 30117728
[TBL] [Abstract][Full Text] [Related]
6.
Barnes CBG; Dans MG; Jonsdottir TK; Crabb BS; Gilson PR
Front Cell Infect Microbiol; 2022; 12():1060202. PubMed ID: 36530423
[TBL] [Abstract][Full Text] [Related]
7. Host Cell Metabolism Contributes to Delayed-Death Kinetics of Apicoplast Inhibitors in Toxoplasma gondii.
Amberg-Johnson K; Yeh E
Antimicrob Agents Chemother; 2019 Feb; 63(2):. PubMed ID: 30455243
[No Abstract] [Full Text] [Related]
8. An image-based high-content screening for compounds targeting
Honfozo A; Houngue R; Vandeputte A; Dechavanne S; Nouatin O; Atindehou MC; Fanou LA; Massougbodji A; Dechavanne C; Brodin P; Tomavo S
Front Cell Infect Microbiol; 2023; 13():1102551. PubMed ID: 36936758
[No Abstract] [Full Text] [Related]
9. Cryogenic electron tomography reveals novel structures in the apical complex of
Sun SY; Segev-Zarko L-a; Pintilie GD; Kim CY; Staggers SR; Schmid MF; Egan ES; Chiu W; Boothroyd JC
mBio; 2024 Apr; 15(4):e0286423. PubMed ID: 38456679
[TBL] [Abstract][Full Text] [Related]
10. The Actinomyosin Motor Drives Malaria Parasite Red Blood Cell Invasion but Not Egress.
Perrin AJ; Collins CR; Russell MRG; Collinson LM; Baker DA; Blackman MJ
mBio; 2018 Jul; 9(4):. PubMed ID: 29970464
[TBL] [Abstract][Full Text] [Related]
11. High-Content Screening of the Medicines for Malaria Venture Pathogen Box for Plasmodium falciparum Digestive Vacuole-Disrupting Molecules Reveals Valuable Starting Points for Drug Discovery.
Tong JX; Chandramohanadas R; Tan KS
Antimicrob Agents Chemother; 2018 Mar; 62(3):. PubMed ID: 29311064
[No Abstract] [Full Text] [Related]
12. Repurposing the Medicines for Malaria Venture's COVID Box to discover potent inhibitors of Toxoplasma gondii, and in vivo efficacy evaluation of almitrine bismesylate (MMV1804175) in chronically infected mice.
Dos Santos BR; Ramos ABDSB; de Menezes RPB; Scotti MT; Colombo FA; Marques MJ; Reimão JQ
PLoS One; 2023; 18(7):e0288335. PubMed ID: 37418497
[TBL] [Abstract][Full Text] [Related]
13. Identification of fungal natural products with potent inhibition in
Jiang T; Godinez-Macias KP; Collins JE; Lee JW; Wendt KL; Carolino K; Chakrabarti D; Cichewicz RH; Winzeler EA
Microbiol Spectr; 2024 Apr; 12(4):e0414223. PubMed ID: 38421191
[TBL] [Abstract][Full Text] [Related]
14. Erratum for Subramanian et al., "Targeted Phenotypic Screening in
Subramanian G; Belekar MA; Shukla A; Tong JX; Sinha A; Chu TTT; Kulkarni AS; Preiser PR; Reddy DS; Tan KSW; Shanmugam D; Chandramohanadas R
mSphere; 2019 Mar; 4(2):. PubMed ID: 30867329
[No Abstract] [Full Text] [Related]
15. Expression of the essential Kinase PfCDPK1 from Plasmodium falciparum in Toxoplasma gondii facilitates the discovery of novel antimalarial drugs.
Gaji RY; Checkley L; Reese ML; Ferdig MT; Arrizabalaga G
Antimicrob Agents Chemother; 2014 May; 58(5):2598-607. PubMed ID: 24550330
[TBL] [Abstract][Full Text] [Related]
16. CRISPR/Cas9-Based Knockout of GNAQ Reveals Differences in Host Cell Signaling Necessary for Egress of Apicomplexan Parasites.
Burda PC; Bisio H; Marq JB; Soldati-Favre D; Heussler VT
mSphere; 2020 Dec; 5(6):. PubMed ID: 33361125
[No Abstract] [Full Text] [Related]
17. Evaluation of Current and Emerging Antimalarial Medicines for Inhibition of Toxoplasma gondii Growth in Vitro.
Radke JB; Burrows JN; Goldberg DE; Sibley LD
ACS Infect Dis; 2018 Aug; 4(8):1264-1274. PubMed ID: 29998728
[TBL] [Abstract][Full Text] [Related]
18. Multiple essential functions of Plasmodium falciparum actin-1 during malaria blood-stage development.
Das S; Lemgruber L; Tay CL; Baum J; Meissner M
BMC Biol; 2017 Aug; 15(1):70. PubMed ID: 28810863
[TBL] [Abstract][Full Text] [Related]
19. Discovery of New Inhibitors of Toxoplasma gondii via the Pathogen Box.
Spalenka J; Escotte-Binet S; Bakiri A; Hubert J; Renault JH; Velard F; Duchateau S; Aubert D; Huguenin A; Villena I
Antimicrob Agents Chemother; 2018 Feb; 62(2):. PubMed ID: 29133550
[No Abstract] [Full Text] [Related]
20. Medicines for Malaria Venture Pandemic Box In Vitro Screening Identifies Compounds Highly Active against the Tachyzoite Stage of
Dos Santos M; Oliveira Costa AL; Vaz GHS; de Souza GCA; Vitor RWA; Martins-Duarte ÉS
Trop Med Infect Dis; 2023 Nov; 8(12):. PubMed ID: 38133442
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
